Breakthroughs

FDA Approves Daraxonrasib (RASONQUE): A New Era for Metastatic Pancreatic Cancer

Daraxonrasib (RASONQUE) pancreatic cancer treatment

Last updated: August 30, 2026

Medical Disclaimer

The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.